Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Gangdong-gu, Korea, Republic of Clinical Trials

A listing of Gangdong-gu, Korea, Republic of clinical trials actively recruiting patients volunteers.

RESULTS

Found (889) clinical trials

Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive

To evaluate safety and efficacy of CE/BZA in real practice in Korea

Phase N/A

4.28 miles

Learn More »

Safety and Effectiveness of BOTOX for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

Phase

4.28 miles

Learn More »

Bortezomib Maintenance in High Risk DLBCL

High-intermediate or high risk in IPI has a long-term chance of cure in the range about 50% in patients with DLBCL treated by R-CHOP. These high risk patients should be considered for additional new treatment to standard R-CHOP or investigational approaches in the context of clinical trials that are designed ...

Phase

4.28 miles

Learn More »

Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness

The difficulties to treat depressed patients are 1)the patients don't respond to antidepressant is about 40% of which, and 2) The time lag is existed until the patients respond to antidepressant and show the treatment effects. If it is predicted the response of antidepressant in advance, it would be overcome ...

Phase N/A

4.28 miles

Learn More »

Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients

The purpose of this study is to determine whether genomic effects on antidepressant response differed by class of drug, whether genomic differences between drug responders and nonresponders predict the response of antidepressant and to construct the prediction model for antidepressant treatment in order to aid to select the their genetically ...

Phase N/A

4.28 miles

Learn More »

Pharmacogenetic Study of Mirtazapine Response in Depressed Patients

The purpose of this study is to determine whether genomic differences between drug responders and nonresponders predict the response of Mirtazapine and to construct the prediction model for Mirtazapine treatment in depressed patients in order to aid to select the genetically matching drug.

Phase N/A

4.28 miles

Learn More »

Predict Antidepressant Responsiveness Using Pharmacogenomics

The primary hypothesis is that the variations of the candidate genes are associated with individual symptoms in patients with depression. The Second hypothesis is that patients with the associated genetic variation suffer longer from the associated symptom than the patients without the associated genetic variation.

Phase N/A

4.28 miles

Learn More »

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort Turbuhaler in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

The purpose of this study is to demonstrate the superiority of CHF 5993 pMDI (fixed combination of extrafine beclometasone dipropionate plus formoterol fumarate plus glycopyrronium bromide) over Symbicort Turbuhaler in terms of pulmonary function, as well as to assess its safety.

Phase

4.28 miles

Learn More »

A Study of NOV1501 (ABL001) in Subject With Advanced Solid Tumors

This is an open-label, Phase 1 dose escalation and expansion study of NOV1501 (ABL001) to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and the anti-tumor efficacy of ABL001 in patients with advanced solid tumors after failure of standard of care. Patients will be enrolled in two stages: a dose-escalation stage and ...

Phase

4.28 miles

Learn More »

Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study

The better understanding of non-Hodgkin T-cell lymphoma is essential for establishing effective treatment strategy for non-Hodgkin T-cell lymphoma. Therefore, the data about conical features and treatment outcomes of each subtype should be accumulated to establish treatment strategy. However, the majority of previous data for non-Hodgkin T-cell lymphoma was from small ...

Phase N/A

4.28 miles

Learn More »